Dosing and uses of Sarilumab
Rheumatoid Arthritis
Pending FDA approval for active, moderate-to-severe rheumatoid arthritis
Pediatric dosage forms and strengths
Safety and efficacy not established
Pharmacology of Sarilumab
Mechanism of action
Human monoclonal antibody directed against the interleukin-6 (IL-6) receptor
